Tuberculosis vaccines: Beyond bacilli Calmette-Guérin

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin

Tuberculosis (TB) disease caused by Mycobacterium tuberculosis (M. tb) remains one of the leading infectious causes of death and disease throughout the world. The only licensed vaccine, Mycobacterium bovis bacille Calmette-Gue ́rin (BCG) confers highly variable protection against pulmonary disease....

Descripció completa

Dades bibliogràfiques
Autor principal:	McShane, H
Format:	Journal article
Idioma:	English
Publicat:	2011

Ítems similars

Tuberculosis vaccines: beyond bacille Calmette–Guérin
per: McShane, H
Publicat: (2011)

Molecular diagnosis of childhood tuberculosis and infection with Bacilli Calmette-Guerin in Taiwan
per: Ruwen Jou, et al.
Publicat: (2011-12-01)

Bacille Calmette-Guérin Vaccination and Tuberculosis
per: Nick R Anthonisen
Publicat: (2005-01-01)

Phosphodiesterases Inhibition by Bacilli Calmette-Guérin Contributes to Decrease Asthma in Allergic Rats
per: Yajuan Wang, et al.
Publicat: (2011-09-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
per: Renata Monteiro-Maia, et al.
Publicat: (2014-09-01)

Timeliness of Bacilli Calmette-Guérin vaccination among infants in a tertiary health facility in sub-Saharan Africa
per: Ekop EE, et al.
Publicat: (2021-07-01)

Effectiveness of bacillus Calmette–Guerin vaccination history on pulmonary tuberculosis symptoms
per: Safar Farajnia, et al.
Publicat: (2019-12-01)

The Use of Bacille Calmette-Guérin vaccination in Children
per: David P Speert
Publicat: (1995-01-01)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
per: Oluwafolajimi A. Adesanya, et al.
Publicat: (2021-02-01)

Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination
per: Sayori Kobayashi, et al.
Publicat: (2021-08-01)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
per: Minassian, A, et al.
Publicat: (2012)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
per: Minassian, A, et al.
Publicat: (2012)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
per: Natalie E. Nieuwenhuizen, et al.
Publicat: (2018-02-01)

Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette–Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases
per: Magdalena Jurczak, et al.
Publicat: (2025-02-01)

The management and outcome of Bacillus Calmette–Guérin vaccine overdose
per: Sung-Hsi Wei, et al.
Publicat: (2018-04-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
per: Rolandas Selvestravičius, et al.
Publicat: (2016-09-01)

Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
per: Helen A. Fletcher
Publicat: (2016-09-01)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
per: Anadi Roy Chowdhury, et al.
Publicat: (2013-01-01)

The Lack of Association Between Bacille Calmette-Guerin Vaccination and Clustering of Aboriginals with Tuberculosis in Western Canada
per: Victoria J Cook, et al.
Publicat: (2005-01-01)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
per: Maria Carolina Sisco, et al.
Publicat: (2020-05-01)

Bacillus Calmette–Guérin and Bladder Cancer
per: Azad H.A. Razack
Publicat: (2007-10-01)

Positive impact of rescheduling Bacillus Calmette-Guérin vaccination on vaccinations at birth
per: Simmi Oberoi, et al.
Publicat: (2017-01-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
per: Lwandile Bukula, et al.
Publicat: (2025-03-01)

Bacillus calmette–Guérin scar inflammation after COVID vaccination
per: B N Shiva Prasad
Publicat: (2022-01-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
per: Sarah Hamdy Soliman, et al.
Publicat: (2023-01-01)

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
per: Patricia Méndez-Samperio
Publicat: (2019-06-01)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
per: Yanin Chavarri-Guerra, et al.
Publicat: (2019-12-01)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
per: Badria Al Waili, et al.
Publicat: (2021-02-01)

Infantile osteoarticular tuberculosis misdiagnosed as Bacillus Calmette-Guerin related osteomyelitis
per: Limpaphayom Noppachart, et al.
Publicat: (2015-01-01)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
per: Fletcher, H, et al.
Publicat: (2016)

A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette–Guérin-vaccinated Individuals
per: Delfina Peña, et al.
Publicat: (2015-08-01)

Bacillus Calmette–Guérin Immunotherapy for Cancer
per: Fabíola Cardillo, et al.
Publicat: (2021-05-01)

Evaluation of the specificity of an intradermal test with recombinant tuberculosis allergen in Bacillus Calmette–Guérin-vaccinated healthy volunteers
per: Irina A. Vasilyeva, et al.
Publicat: (2023-03-01)

Effectiveness Of Bacillus Calmette Guerin (BCG) Vaccination In The Prevention Of Tuberculosis Of Skin : A Case Control Study.
per: Zodpey S.P, et al.
Publicat: (1998-01-01)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
per: Minhinnick, A, et al.
Publicat: (2015)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
per: Paola Villanueva, et al.
Publicat: (2022-01-01)

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
per: Sara Feola, et al.
Publicat: (2021-07-01)

Research progress in the off-target effects of Bacille Calmette–Guérin vaccine
per: Yanfei Wu, et al.
Publicat: (2024-09-01)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
per: Junli Li, et al.
Publicat: (2021-01-01)

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China
per: Junli Li, et al.
Publicat: (2022-07-01)